Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;1821(5):747-53.
doi: 10.1016/j.bbalip.2011.09.017. Epub 2011 Oct 8.

Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

Affiliations
Review

Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

Anne P L Jensen-Urstad et al. Biochim Biophys Acta. 2012 May.

Abstract

Fatty acid synthase (FAS) catalyzes the de novo synthesis of fatty acids. In the liver, FAS has long been categorized as a housekeeping protein, producing fat for storage of energy when nutrients are present in excess. Most previous studies of FAS regulation have focused on the control of gene expression. However, recent findings suggest that hepatic FAS may also be involved in signaling processes that include activation of peroxisome proliferator-activated receptor α (PPARα). Moreover, reports of rapid alterations in FAS activity as well as findings of post-translational modifications of the FAS protein support the notion that dynamic events in addition to transcription impact FAS regulation. These results indicate that FAS enzyme activity can impact liver physiology through signaling as well as energy storage and that its regulation may be complex. This article is part of a Special Issue entitled Triglyceride Metabolism and Disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The role of FAS in hepatic triglyceride metabolism
Fatty acid synthase controls fatty acid catabolism through the synthesis of a ligand for PPARα, which activates fatty acid oxidation genes. FAS makes a minor contribution of lipids to stored and secreted triglycerides, with the major contributions coming from plasma free fatty acids and dietary fats from chylomicron remnants. 16:0/18:1 GPC, 16:0/18:1-glycerophosphocholine; DAG, diacylglycerol; FAS, fatty acid synthase; FFA, free fatty acid; PPARα, peroxisome proliferator-activated receptor alpha; RXR, retinoid X receptor; TAG, triacylglycerol (triglyceride); VLDL, very low-density lipoprotein.
Figure 2
Figure 2. The mouse proximal FAS promoter
Regulatory elements and nuclear factor binding site nucleotides are highlighted in yellow. IRE, insulin response element; LXRE, liver X receptor element; Nf-Y, nuclear factor Y binding site; Sp1, specificity factor 1 binding site; SRE, sterol regulatory element.

Similar articles

Cited by

References

    1. Wu M, Singh SB, Wang J, Chung CC, Salituro G, Karanam BV, Lee SH, Powles M, Ellsworth KP, Lassman ME, Miller C, Myers RW, Tota MR, Zhang BB, Li C. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A. 2011;108:5378–5383. - PMC - PubMed
    1. Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438. - PubMed
    1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. - PubMed
    1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. - PubMed
    1. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B. - PubMed